Results from two early clinical trials show that it may be possible to use human embryonic stem cells as treatment for the dry form of macular degeneration, according to presentations given today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
Research to Prevent Blindness and the American Academy of Ophthalmology today announced that they have created a new category of grant to support researchers who want to use the Academy’s IRIS(r) Registry database to conduct population-based studies in ophthalmology and blindness prevention.
The American Academy of Ophthalmology today announced key milestones and clinical insights from studies powered by its clinical database. The IRIS(r) Registry (Intelligent Research In Sight) has amassed more than 41.2 million unique patients in its database, representing 166.2 million patient visits, covering 11 percent of the U.S. population.
Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
Next week, thousands of eye physicians and surgeons will attend AAO 2017, the American Academy of Ophthalmology’s 121st annual meeting.
Children who are considered to be at risk of developing eye cancer should receive genetic counseling and testing as soon as possible to clarify risk for the disease. This is the consensus of leading ophthalmologists, pathologists and geneticists, who worked to develop the first U.S. guidelines on how to screen for the most common eye tumor affecting children.